1. [Status of cellular immunity in patients with Astrakhan fever].
- Author
-
Kasimova NB, Kulikova IN, Karpenko SF, Burkin VS, Altukhov SA, Arshba TE, and Aĭrapetova GS
- Subjects
- Adolescent, Adult, Aged, Boutonneuse Fever drug therapy, Doxycycline therapeutic use, Humans, Interferon Type I therapeutic use, Interferon alpha-2, Interferon-alpha, Middle Aged, Recombinant Proteins, Rifampin therapeutic use, B-Lymphocytes immunology, Boutonneuse Fever immunology, T-Lymphocytes immunology
- Abstract
Aim: To ascertain regularities of development of cellular immunity in patients with Astrakhan fever (AF) with reference to AF severity, treatment and course., Material and Methods: Cellular factors of immunity--relative and absolute contents of T-lymphocytes (early and late), T-helpers and T-suppressors, B-lymphocytes, neutrophils (early and late)--were studied in 75 patients with AF (63 patients with moderate and 12 patients with severe disease) in the course of the disease progression (weeks 1-5). The patients received antibacterial treatment--doxicyclin, rifampicin and doxicycline in combination with alpha 2-realdiron and gamma-reaferon., Results: Examination of immunocompetent cells has revealed suppression of T- and B-immunity for 2 weeks in moderate AF and 3 weeks in severe AF. The number of T-helpers was low for 3 weeks while of T-suppressors rose beginning from week 2. Immunoregulatory index Tx/Tc remains low till the end of the disease. The number of early and late neutrophils increased since weeks 2 of the disease in moderate and week 3 in severe AF., Conclusion: Doxicycline efficiency was higher than that of rifampicin. Interferon preparations decrease relative number of early and late T-lymphocytes, neutrocytes and T-helpers but their absolute number is at the control level. Relative content of T-suppressors and B-lymphocytes is as in controls but their absolute content is higher.
- Published
- 2002